We are live on ! Find out more
RPID icon

Rapid Micro Biosystems

26 hedge funds and large institutions have $14.9M invested in Rapid Micro Biosystems in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

13% more funds holding

Funds holding: 2326 (+3)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

3.77% less ownership

Funds ownership: 57.96%54.19% (-3.8%)

36% less capital invested

Capital invested by funds: $23.2M → $14.9M (-$8.3M)

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.38%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
6
Reduced
5
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$6.24M
KLM
2
Kennedy Lewis Management
New York
$3.66M
GCM
3
Glenview Capital Management
New York
$976K
AWGLSCP
4
ABG-WTT Global Life Science Capital Partners
Hong Kong
$768K
BlackRock
5
BlackRock
New York
$756K -$676 -661 -0.1%
JP Morgan Chase
6
JP Morgan Chase
New York
$556K -$699K -682,916 -48%
Vanguard Group
7
Vanguard Group
Pennsylvania
$539K +$2.4K +2,350 +0.3%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$518K
AI
9
Advent International
Massachusetts
$428K
Goldman Sachs
10
Goldman Sachs
New York
$162K -$747K -729,494 -77%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$115K
Renaissance Technologies
12
Renaissance Technologies
New York
$58K +$56.8K +55,500 +248%
State Street
13
State Street
Massachusetts
$19.3K
Citadel Advisors
14
Citadel Advisors
Florida
$17.9K +$7.67K +7,494 +45%
Morgan Stanley
15
Morgan Stanley
New York
$15.8K +$10.9K +10,644 +100%
Millennium Management
16
Millennium Management
New York
$12.7K -$7.99K -7,810 -31%
VF
17
Virtu Financial
New York
$12K +$16.4K +16,064 New
Northern Trust
18
Northern Trust
Illinois
$11.6K -$3.37K -3,294 -17%
XT
19
XTX Topco
Cayman Islands
$7.74K +$10.7K +10,463 New
TRCT
20
Tower Research Capital (TRC)
New York
$7.26K +$6.81K +6,655 +211%
Wells Fargo
21
Wells Fargo
California
$114 +$8 +8 +5%
ASN
22
Advisory Services Network
Georgia
$74 +$102 +100 New
Bank of America
23
Bank of America
North Carolina
$10 +$14 +14 New
Qube Research & Technologies (QRT)
24
Qube Research & Technologies (QRT)
United Kingdom
$3
PL
25
Parkwood LLC
Ohio
-$26K -24,511 Closed

RPID Hedge Fund Activity: Q4 2023 in Review

26 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Rapid Micro Biosystems (RPID) for Q4 2023, worth a combined $14.9M — down 36% from $23.2M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new RPID positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 5 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $56.8K. The largest seller was Goldman Sachs, cutting an estimated $747K.

  • 26 institutional investors held Rapid Micro Biosystems (RPID) as of Q4 2023, up from 23 in Q3 2023.
  • Funds reported $14.9M of Rapid Micro Biosystems stock for Q4 2023, down 36% quarter-over-quarter.
  • 5 funds opened new Rapid Micro Biosystems positions in Q4 2023 and 2 closed out, a net change of +3 holders.
  • The largest Rapid Micro Biosystems buyer in Q4 2023 was Renaissance Technologies, an estimated $56.8K added.
  • The largest Rapid Micro Biosystems seller in Q4 2023 was Goldman Sachs, an estimated $747K sold.

Based on aggregated 13F filings for Q4 2023.